MedicaidCoverageMedium impact
Emergency Tamiflu and Oseltamivir Shortage Compounding Instructions
Illinois Medicaid - HFS·IL · Pharmacy, Pediatrics, Family Medicine +1 more·Provider Notice
Effective date
Dec 9, 2022
We identified it
Jun 20, 2026
Summary
Due to Tamiflu/oseltamivir shortage, Illinois Medicaid will temporarily reimburse brand name Tamiflu and compounded suspensions without prior authorization. The policy provides detailed compounding instructions for pharmacies when commercial oral suspension is unavailable.
Action Required
Immediately: Billing team should verify that brand name Tamiflu claims to Illinois Medicaid process without prior authorization requirements. Pharmacies compounding oseltamivir suspension should follow the specific weight-based compounding instructions and storage requirements outlined in the policy. Monitor for future updates when commercial availability is restored.